1. About Us
  2. Partners

Partners

As with any successful research enterprise the key to success is establishing and maintaining strong networks and partnerships with local, national, and international collaborators, as well as funders, patients and benefactors.

Host Institutions

Vancouver Coastal Health Research Institute University of British Columbia
UBC Faculty of Medicine Department of Urologic Sciences, UBC

Our Valuable Partners Include:

Accel-Rx BC Cancer Agency
Government of Canada Canada Foundation for Innovation
Canadian Cancer Society CIHR
CDRD

Coalition to Cure Prostate Cancer
Genome British Columbia Genome Canada
Michael Smith Foundation for Health Research Movember Foundation
Networks of Centres of Excellence of Canada Prostate Cancer Canada
Prostate Cancer Foundation Prostate Cancer BC
Provincial Health Services Authority The Terry Fox Foundation
VGH & UBC Hospital Foundation

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Learn More

News

March
08
Recent publications identify new targets for prostate cancer research
February
20
Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy
February
07
ASCO merit award & SWOG young investigator award for VPC and BCCA clinician-scientist
February
02
VPC scientist receives award for fundamental research publication
See All News  
Watch Tom's Story:
Prostate cancer awareness and fundraising

Events

PCF BC

Ride to Live 2018 and 50-50 Draw: May 27

The West Coast Motorcycle Ride to Live, raising funds for Prostate Cancer Foundation BC, takes place on Sunday May 27, 2018 in Vancouver, Victoria & the Fraser Valley. Follow the links to join a ride or donate to a rider; or to buy a ticket for a 50/50 draw (BC residents only).

Employment

Work at the Vancouver Prostate Centre

Learn More
Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Learn More
Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy
Learn More
Dr. Nappi
February
07
ASCO merit award & SWOG young investigator award for VPC and BCCA clinician-scientist
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.